Guidelines and definitions for research on epithelial-mesenchymal transition
Open accessThe DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
Epithelial–mesenchymal transition (EMT) encompasses dynamic changes in cellular organization from epithelial to mesenchymal phenotypes, which leads to functional changes in cell migration and invasion. EMT occurs in a diverse range of physiological and pathological conditions and is driven by a conserved set of inducing signals, transcriptional regulators and downstream effectors. With over 5,700 publications indexed by Web of Science in 2019 alone, research on EMT is expanding rapidly. This growing interest warrants the need for a consensus among researchers when referring to and undertaking research on EMT. This Consensus Statement, mediated by ‘the EMT International Association’ (TEMTIA), is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications. We trust that these guidelines will help to reduce misunderstanding and misinterpretation of research data generated in various experimental models and to promote cross-disciplinary collaboration to identify and address key open questions in this research field. While recognizing the importance of maintaining diversity in experimental approaches and conceptual frameworks, we emphasize that lasting contributions of EMT research to increasing our understanding of developmental processes and combatting cancer and other diseases depend on the adoption of a unified terminology to describe EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epithelial-to-mesenchymal transition (EMT) is another potential mechanism of both intrinsic and acquired resistance to KRASG12C inhibitors.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of canonical EMT transcription factors, including Snai1/2, Zeb1/2, and Twist1, is observed in both contexts77.”
From Cell diversity and plasticity during atrioventricular heart valve EMTs (2023) · cites this paper as [77]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A major challenge in the field has been to reliably identify senescent cells in tissues and organs.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Self-citationNew insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Self-citationCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Self-citationEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Self-citationBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Self-citationZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Self-citationFischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Research works printed but not linked: 1
- Hay, E. D. in Epithelial–Mesenchymal Interactions: 18th Hahnemann Symposium (eds R. Fleischmajer & Billingham, R. E.) 31–35 (Williams and Wilkins, 1968).
Cited by
Items 501–600 of 1,001
Sahoo, S., Ashraf, B., Duddu, A. S., Biddle, A., & Jolly, M. K. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10139-2 · Cited by 28
“The necessary and sufficient conditions for calling a cell a CSC at a point of time needs some community-level consensus, perhaps an attempt similar to the one recently attempted to define EMP [75].”
ResultImpact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer
Yamaguchi, K., Yamamoto, T., Chikuda, J., Shirota, T., & Yamamoto, Y. (2022) · Biomolecules · doi:10.3390/biom12020284 · Cited by 28
“Epithelial-to-mesenchymal transition (EMT) is an important biological feature in the developmental process and in wound healing, in which epithelial cells lose their polarity and intercellular tight junctions and acquire mesenchymal-like cell traits accompanied by invasion and migration capabilities [24,25].”
BackgroundTian, L., Long, F., Hao, Y., Li, B., Li, Y., Tang, Y., Li, J., Zhao, Q., Chen, J., & Liu, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.880326 · Cited by 28
Tang, W., Watson, C. J., Olmstead, T., Allan, C. H., & Kwon, R. Y. (2022) · iScience · doi:10.1016/j.isci.2022.103784 · Cited by 28
3D genome organization in the epithelial-mesenchymal transition spectrum
Pang, Q. Y., Tan, T. Z., Sundararajan, V., Chiu, Y.-C., Chee, E. Y. W., Chung, V. Y., Choolani, M. A., & Huang, R. Y. (2022) · Genome biology · doi:10.1186/s13059-022-02687-x · Cited by 28
Self-citationDown-regulation of MSMO1 promotes the development and progression of pancreatic cancer
Cao, R., Zhang, Z., Tian, C., Sheng, W., Dong, Q., & Dong, M. (2022) · Journal of Cancer · doi:10.7150/jca.73112 · Cited by 28
“Epithelial-mesenchymal transition (EMT) is a cellular process initiated from cellular micro environment following the acquisition of mesenchymal phenotypes and the repression of epithelial features, which finally contributes to the cell invasion and metastasis of cancer, including PC [4, 5].”
BackgroundInfluentialXing, J. (2022) · Physical Biology · doi:10.1088/1478-3975/ac8c16 · Cited by 28
“For example, studies on the epithelial-tomesenchymal transition (EMT) lead to a consensus that it is insufficient to use a small number of markers to reflect the progression of the process [70].”
Self-citationResistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer
Saini, M., Schmidleitner, L., Moreno, H. D., Donato, E., Falcone, M., Bartsch, J. M., Klein, C., Vogel, V., Würth, R., Pfarr, N., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112533 · Cited by 28
Orrapin, S., Thongkumkoon, P., Udomruk, S., Moonmuang, S., Sutthitthasakul, S., Yongpitakwattana, P., Pruksakorn, D., & Chaiyawat, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512337 · Cited by 28
“bloodstream until undergoing mesenchymal-to-epithelial transitions (MET) and restoring their epithelial character to extravasate and colonize distant sites [7].”
BackgroundKuburich, N. A., den Hollander, P., Castañeda, M., Pietilä, M., Tang, X., Batra, H. V., Martínez‐Peña, F., Visal, T. H., Zhou, T., Demestichas, B. R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113470 · Cited by 28
“59 Carcinoma cells that initiate the EMT program have increased migratory, invasive, and stemness phenotypes, 6,11,60–63 and CSCs, which have innate self-renewal and differentiation properties, fuel malignancy and recurrence.”
BackgroundSelf-citationNew Insights into Therapy-Induced Progression of Cancer
Shnaider, P. V., Ivanova, O. M., Malyants, I. K., Anufrieva, K. S., Semenov, I. A., Pavlyukov, M. S., Lagarkova, M. A., Govorun, V. M., & Shender, V. О. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217872 · Cited by 29
“In addition, it should be borne in mind that EMT activation programs may differ depending on the type of tissue as well as the specific tumor microenvironment [92,95].”
BackgroundThe role of miR-200b/c in balancing EMT and proliferation revealed by an activity reporter
Gollavilli, P. N., Parma, B., Siddiqui, A., Yang, H., Ramesh, V., Napoli, F., Schwab, A., Natesan, R., Mielenz, D., Asangani, I. A., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01708-6 · Cited by 28
“Although a few markers like E-Cadherin, Vimentin and ZEB1 can represent a good surrogate for the determination of the EMT state [14, 30], this should be better concluded from broader, and possibly genome-wide characterizations [31].”
BackgroundSelf-citationMesenchymal-to-epithelial transitions require tissue-specific interactions with distinct laminins
Pitsidianaki, I., Morgan, J., Adams, J., & Campbell, K. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202010154 · Cited by 28
Self-citationZhang, Q., Lin, F., Huang, J., & Xiong, C. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2054-3 · Cited by 28
“, 2017), the precise role of EMT in tumor cell migration from the primary tumor site to secondary locations during the invasion-metastasis cascade has remained ambiguous (Williams et al., 2019; Yang et al., 2020), especially the under-”
BackgroundThe relationship between cancer and biomechanics.
Bao, L., Kong, H., Ja, Y., Wang, C., Qin, L., Sun, H., & Dai, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1273154 · Cited by 27
Withnell, E., & Secrier, M. (2024) · Genome biology · doi:10.1186/s13059-024-03428-y · Cited by 27
“During EMT, polarised epithelial cells undergo multiple molecular changes and lose their identity to acquire a mesenchymal phenotype(27).”
BackgroundIntestinal fibrosis associated with inflammatory bowel disease: Known and unknown
Zhang, Y., Zhuang, H., Chen, K., Zhao, Y., Wang, D., Ran, T., & Zou, D. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003545 · Cited by 28
“[75] In the fibrotic areas of CD patients, several features of EMT have been observed, including a decrease in the expression of the epithelial marker β -catenin and an increase in the transcription factor SLUG.”
Lundberg, A. S., Geuijen, C. A. W., Hill, S., van Bueren, J. J. L., Fumagalli, A., de Kruif, J., Silverman, P. B., & Tabernero, J. M. (2025) · Cancers · doi:10.3390/cancers17101665 · Cited by 27
“These more malignant “cancer driver” cells have been described as less differentiated, more stem-cell-like, and displaying partial epithelial to mesenchymal transition [8,9]; they are also thought to be a major source of treatment failure [10].”
Bastos, V. A. F., de Souza, A. G., Guedes, V. C. S., & Cunha, T. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199476 · Cited by 27
“…that EMT does not occur as a binary switch between epithelial and mesenchymal states, but rather as a spectrum of intermediate cellular phenotypes, often referred to as hybrid or pEMT states, which endow cells with enhanced functional plasticity in both tumors and fibrotic tissues [4,5,13].”
Baldini, E., Tuccilli, C., Pironi, D., Catania, A., Tartaglia, F., Matteo, F. M. D., Palumbo, P., Arcieri, S., Mascagni, D., Palazzini, G., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184076 · Cited by 27
“Although a more complete characterization is needed, on the whole, these results suggest that EMT is not particularly evident in PTC, because the downregulation of E-cadherin—one of the main initiation events of EMT—occurs, but the vimentin expression remains unchanged, and the EMT-TFs are even reduced [7].”
BackgroundDPYSL2 interacts with JAK1 to mediate breast cancer cell migration
Rmaileh, A. A., Solaimuthu, B., Khatib, A., Lavi, S., Tanna, M., Hayashi, A., Yosef, M. B., Lichtenstein, M., Pillar, N., & Shaul, Y. D. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202106078 · Cited by 27
“To traverse a substantial distance, the metastatic cancer cells undergo profound alterations in cellular characteristics (Brabletz et al., 2021), proposed to be induced by the epithelial – mesenchymal transition (EMT) program (Yang et al., 2020).”
Wang, Y., Wang, Y., Liu, R., Wang, C., Luo, Y., Chen, L., He, Y., Zhu, K., Guo, H., Zhang, Z., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01176-1 · Cited by 27
“Generally, tumor epithelial cells depend on the activation of EMT to acquire distinct mesenchymal traits that confer to cells the ability to invade adjacent tissues and then to disseminate over a distance [15, 25].”
BackgroundOuyang, J., Li, J., Li, D., Jiang, J., Hao, T., Xia, Y., Lu, X., Zhang, C., & He, Y. (2022) · Cancers · doi:10.3390/cancers14215381 · Cited by 28
“EMT is a highly complex and dynamic process in which the epithelial features of tumor cells (including stable epithelial cell-cell junctions, apical-basal polarity, and interactions with basement membrane) are suppressed by gene expression changes and post-translational regulatory mechanisms, with obtaining mesenchyma…”
BackgroundNzeteu, G. A. N., Geismann, C., Arlt, A., Hoogwater, F. J. H., Nijkamp, M. W., Meyer, N. H., & Bockhorn, M. (2022) · Cancers · doi:10.3390/cancers14225483 · Cited by 27
“to as E/M or p rt al EMT states, in vivo [101,102].”
BackgroundShi, S., Roest, H. P., van den Bosch, T. P. P., Bijvelds, M. J. C., Boehnert, M. U., de Jonge, J., Dekker, S. O., de Vries, A. A. F., de Jonge, H. R., Verstegen, M. M. A., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2022.104431 · Cited by 27
Cadmium promotes colorectal cancer metastasis through EGFR/Akt/mTOR signaling cascade and dynamics
Sun, M., Jiang, Z., Gu, P., Guo, B., Li, J., Cheng, S., Ba, Q., & Wang, H. Z. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.165699 · Cited by 27
Dissecting pulmonary fibroblasts heterogeneity in lung development, health and diseases
Zhang, X., Shi, X., Xie, F., Liu, Y., Wei, X., Cai, Y., & Chao, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19428 · Cited by 27
POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer
Chen, H., Ma, L., Yang, W., Li, Y., & Ji, Z. (2023) · The FASEB Journal · doi:10.1096/fj.202301095r · Cited by 27
Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy
Din, Z. U., Cui, B., Wang, C., Zhang, X., Mehmood, A., Peng, F., & Liu, Q. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04995-1 · Cited by 27
“EMT is a cellular process in which epithelial cells attain mesenchymal properties and behavior which result in the transformation of epithelial cell structure [10], as shown in Fig.”
Nilchian, A., Γιωτοπούλου, Ν., Sun, W., & Fuxe, J. (2020) · Biomolecules · doi:10.3390/biom10121621 · Cited by 27
“Malignant progression of breast cancer is associated with re-activation of epithelial-mesenchymal transition (EMT), a latent developmental process [1,2].”
Self-citationXu, S., Han, C., Zhou, J., Yang, D., Dong, H. F., Zhang, Y., Zhao, T., Tian, Y., & Wu, Y. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-03952-1 · Cited by 26
Cai, Y., Kang, X., Zhou, L., Wu, S., Wang, C., Wu, S., Huang, C.-H., Wang, Q., Chang, Y., Babu, R. J., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202425286 · Cited by 26
Hao, F., Fei, X., Ren, X., Xiao, J. X., Chen, Y., & Wang, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15790 · Cited by 26
Esquer, H., Zhou, Q., Nemkov, T. G., Abraham, A. D., Rinaldetti, S. L., Chen, Y., Zhang, X., Orman, M. V., D’Alessandro, A., Ferrer, M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01728-2 · Cited by 26
Du, M., Hu, X., Jiang, X., Yin, L., Chen, J., Wen, J., Fan, Y., Peng, F., Qian, L., Wu, J., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.55557 · Cited by 26
Nan, N., Duan, H., Yang, X., Wang, L., Liu, A., Chen, R., Qin, G., & Sang, N. (2021) · Atmospheric Pollution Research · doi:10.1016/j.apr.2021.101122 · Cited by 26
Wu, W., Wang, Y., Niu, C., Wahafu, A., Huo, L., Guo, X., Xiang, J., Li, X., Xie, W., Bai, X., et al. (2021) · Cancer Science · doi:10.1111/cas.15233 · Cited by 26
Ding, S., Wang, X., Lv, D., Tao, Y., Liu, S., Chen, C., Huang, Z., Zheng, S., Wei, Y., Kang, T., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.010 · Cited by 26
Du, Q., Liu, S., Dong, K., Cui, X., Luo, J., & Geller, D. A. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0509 · Cited by 26
“RNA-seq data indicated that iNOS knockdown upregulated EMT-TFs and EMT inducers, including SNAIL2, ZEB2, TWIST1, ALX1, E2–2 (TCF4), FOXC1 (23), GSC (gooscoid), ID1, KLF8, SIX1, TWIST2, and other EMT inducers, GATA4, GATA6 (22) and TUSC3 (Fig.”
BackgroundInfluentialFuertes, G., del Valle‐Pérez, B., Pastor, J., Andrades, E., Peña, R., de Herreros, A. G., & Duñach, M. (2023) · EMBO Reports · doi:10.15252/embr.202254895 · Cited by 26
“Snail1 is a transcriptional factor essential for triggering EMT, a process leading to the acquisition of fibroblastic features by epithelial cells (Baulida et al , 2019; Yang et al , 2020).”
GH and IGF1 in cancer therapy resistance
Basu, R., & Kopchick, J. J. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0414 · Cited by 26
Gu, Y., Zhang, Z., Camps, M. G. M., OSSENDORP, F. A., Wijdeven, R. H. M., & ten Dijke, P. (2023) · Science Advances · doi:10.1126/sciadv.adf9915 · Cited by 26
Jain, P., Pillai, M., Duddu, A. S., Somarelli, J. A., Goyal, Y., & Jolly, M. K. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.09.007 · Cited by 26
Epithelial–mesenchymal transition changes in nonsmall cell lung cancer patients with early COPD
Lu, W., Eapen, M. S., Hardikar, A., Chia, C., Robertson, I. K., Singhera, G. K., Hackett, T., & Sohal, S. S. (2023) · ERJ Open Research · doi:10.1183/23120541.00581-2023 · Cited by 26
“EMT-mediated fibrosis is also one of the causes of lung cancer [23].”
BackgroundWang, X., Li, N., Zheng, M., Yu, Y., & Zhang, S. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101815 · Cited by 26
“Many studies have exploited this plasticity to investigate treatment options by inducing the differentiation of cancer cells into benign cells after forced EMT [150,151].”
BackgroundWang, J., Ling, R., Zhou, Y., Gao, X., Yang, Y., Mao, C., & Chen, D. (2020) · Oncology Letters · doi:10.3892/ol.2020.11853 · Cited by 26
“Unlimited proliferation leads to further malignancy of the tumor, and EMT is an essential step that occurs during cancer migration and invasion (52).”
Li, Y., Basti, A., Yalçın, M., & Relógio, A. (2020) · iScience · doi:10.1016/j.isci.2020.101551 · Cited by 26
Cell Competition Boosts Clonal Evolution and Hypoxic Selection in Cancer
Madan, E., Peixoto, M. L., Dimitrion, P. M., Eubank, T. D., Yekelchyk, M., Talukdar, S., Fisher, P. B., Mi, Q., Moreno, E., & Gogna, R. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.10.002 · Cited by 26
“The mechanisms involve the regulation of proteins such as E-cadherin and increase of mesenchymal markers [79].”
BackgroundXu, Y., Hu, S., Chen, R., Xu, S., Yu, G., & Ji, L. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10731-9 · Cited by 25
Defining breast epithelial cell types in the single-cell era
Gray, G. K., Carlson, E. G., Lev, T., Marshall, B., Reed, A. D., Covarrubias, A. P. S., Twigger, A., Puig-Barbe, A., Thennavan, A., Omotoso, A. J., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.06.032 · Cited by 25
Zhang, X., Du, Y., Behrens, A., & Lan, L. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.07.002 · Cited by 25
Emerging roles of N6-methyladenosine (m6A) modification in breast cancer
Wang, Y., Zhang, Y., Du, Y., Zhou, M., Hu, Y., & Zhang, S. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00502-3 · Cited by 25
Yu, X., Wang, Q., Liu, B., Zhang, N., & Cheng, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.684855 · Cited by 25
“Frontiers in Cell and Developmental Biology | www.frontiersin.org 1 August 2021 | Volume 9 | Article 684855 Up to now, there are several reports exploring the association between vitamin D and cancer risk, especially in CRC (Urashima et al., 2019; Yonaga et al., 2019; Amrein et al., 2020).”
BackgroundGiordano, G., Merlini, A., Ferrero, G., Mesiano, G., Fiorino, E., Brusco, S., Centomo, M. L., Leuci, V., D’Ambrosio, L., Aglietta, M., et al. (2021) · Cells · doi:10.3390/cells10112893 · Cited by 25
“Indeed, we could speculate that the high expression levels of EPHA2 observed in our analysis in aggressive epithelial cancers, such as pancreatic and gastric cancer, could reflect EMT activation in these histotypes.”
BackgroundA specialist-generalist framework for epithelial-mesenchymal plasticity in cancer
Cook, D. P., & Wrana, J. L. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.01.014 · Cited by 26
Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression
Chehade, H., Tedja, R., Ramos, H., Bawa, T. S., Adzibolosu, N. K., Gogoi, R. P., Mor, G., & Alvero, A. B. (2022) · Cancers · doi:10.3390/cancers14092267 · Cited by 25
Crumbs complex–directed apical membrane dynamics in epithelial cell ingression
Simões, S. D. M., Lerchbaumer, G., Pellikka, M., Giannatou, P., Lam, T., Kim, D.-H., Yu, J. C., ter Stal, D., Kakouni, K. A., Fernández‐González, R., et al. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202108076 · Cited by 26
“EMT is thought to be initiated by the expression of EMT transcription factors (EMT-TFs) of the Snail, Zeb, or bHLH families that downregulate key adhesion or polarity proteins such as Ecad and Crb [Lamouille et al., 2014; Nieto et al., 2016; Dongre and Weinberg, 2019; Yang et al., 2020].”
BackgroundInfluentialSchuhwerk, H., Kleemann, J., Gupta, P., van Roey, R., Armstark, I., Kreileder, M., Feldker, N., Ramesh, V., Hajjaj, Y., Fuchs, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111819 · Cited by 25
Self-citationKralj, J., Pernar, M., Dabelić, S., Polančec, D. S., Wachtmeister, T., Köhrer, K., & Brozović, A. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02140-1 · Cited by 25
“Moreover, these studies showed that although it would be expected that cell subpopulations with high expression of mesenchymal markers would be the most resistant ones, those with non-definable expressions of EMT markers, characterised as ‘intermediate/hybrid EMT phenotype’ [13], often had more substantial metastatic…”
BackgroundYang, X., & Zhu, W. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11845 · Cited by 25
Cao, R., Li, N. T., Latour, S., Cadavid, J. L., Tan, C. M., Forman, A., Jackson, H. W., & McGuigan, A. P. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202422 · Cited by 25
Dou, R., Han, L., Yang, C., Fang, Y., Zheng, J., Liang, C., Song, J., Chen, W., Huang, G., Zhong, P., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1432 · Cited by 25
“25 Among them, numerous studies reported that SLUG, as a core EMT-TF, promotes tumour metastasis.”
BackgroundBoo, Y. C. (2024) · Antioxidants · doi:10.3390/antiox13020146 · Cited by 25
“EMT is a process of cell transdifferentiation that occurs during the development of many tissues [103].”
BackgroundActomyosin forces in cell migration: Moving beyond cell body retraction
Weißenbruch, K., & Mayor, R. (2024) · BioEssays · doi:10.1002/bies.202400055 · Cited by 25
Self-citationKurmyshkina, O. V., Kovchur, P. I., Schegoleva, L. V., & Volkova, T. O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186515 · Cited by 25
“Inside the CK (+) subset, the proportion of EpCAM (+) cells, being first increased (in CIN1), tended to decrease in high-grade CIN and cancer, indicating that the development of invasive cervical carcinoma may be accompanied with expansion of cells that lose their EpCAM expression, whilst preserve cytokeratins, which…”
BackgroundMethodInfluentialEmerging paradigms in metastasis research
Pari, A. A. A., Singhal, M., & Augustin, H. G. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190218 · Cited by 25
Sinha, V. C., Rinkenbaugh, A. L., Xu, M., Zhou, X., Zhang, X., Jeter-Jones, S. L., Shao, J., Qi, Y., Zebala, J. A., Maeda, D. Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25240-z · Cited by 25
Time to infer miRNA sponge modules
Zhang, J., Liu, L., Xu, T., Zhang, W., Li, J., Rao, N., & Le, T. D. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1686 · Cited by 25
“EMT is not only occurs in normal tissues during development and wound healing, but also acts a driver in organ fibrosis and cancer progression (J. Yang et al., 2020).”
BackgroundSheng, D., Zhao, B., Zhu, W., Wang, T., & Peng, Y. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03587-0 · Cited by 25
Chen, X., Liu, Y., Tao, B.-Y., Xue, X., Zhang, X., Wang, L., Zhong, H., Zhang, J., Yang, S., & Jiang, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.975847 · Cited by 25
“The expression of E-cadherin, tight junction protein 1 (ZO-1), cytokeratin (CK) and other cell adhesion molecules in epithelial tissues is inhibited, whereas the expression of N-cadherin, vimentin (VIM), a-smooth muscle actin (a-SMA/ACTA2), fibroblast specific protein 1 (FSP1/ S100A4) and Osteopontin in mesenchymal ce…”
BackgroundOpposing Nodal and Wnt signalling activities govern the emergence of the mammalian body planPreprint
Dias, A., Pascual-Mas, P., Robertson, G., Torregrosa-Cortés, G., Stelloo, S., Casaní-Galdón, P., Babin, S., Romaniuk, Y., Mayran, A., Wehmeyer, A. E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.11.632562 · Cited by 25
Hosseinirad, H., Jeong, J., & Barrier, B. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157460 · Cited by 24
“These factors can act on multiple cell types, including stromal and immune cells, amplifying the inflammatory and fibrotic responses within the lesion [9].”
Kobayashi, G. S., Musso, C. M., Moreira, D. D. P., Pontillo-Guimarães, G., Hsia, G. S. P., de Caires-Junior, L. C., Goulart, E., & Passos‐Bueno, M. R. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.07.023 · Cited by 24
“In humans, the study of EMT is largely restricted to cancer cells and fibrosis, and knowledge on human NC EMT has been inferred from observations in animal models (Theveneau and Mayor, 2012; Yang et al., 2020).”
BackgroundRegulation of Chromatin Organization in Cell Stemness: The Emerging Role of Long Non-coding RNAs
Dehghani, H. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10209-8 · Cited by 24
Greco, L., Rubbino, F., Morelli, A., Gaiani, F., Grizzi, F., de’Angelis, G. L., Malesci, A., & Laghi, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111469 · Cited by 24
Zhang, Y., Elechalawar, C. K., Yang, W., Frickenstein, A. N., Asfa, S., Fung, K.-M. A., Murphy, B., Dwivedi, S. K. D., Rao, G., Dey, A., et al. (2022) · Materials Today · doi:10.1016/j.mattod.2022.01.025 · Cited by 24
The function and regulation network mechanism of circRNA in liver diseases
Wang, P., Zhang, Y., Deng, L., Qu, Z., Guo, P., Liu, L., Yu, Z., Wang, P., & Liu, N. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02559-1 · Cited by 25
“Epithelial to mesenchymal transition (EMT) refers to a biological process of epithelial cells transforming from differentiated properties to mesenchymal characteristics [85], it is a key part of cancer metastasis [86].”
BackgroundLotsberg, M. L., Røsland, G. V., Rayford, A. J., Dyrstad, S. E., Ekanger, C. T., Lü, N., Frantz, K., Stuhr, L. E. B., Ditzel, H. J., Thiery, J. P., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.818437 · Cited by 24
“Therefore, this study aimed to develop and characterize a 3D heterotypic co-culture system consisting of EGFRi-sensitive or EGFRi-resistant NSCLC cells together with fibroblasts that can be applied to study the impact of cancer-stroma interactions and EMP on acquired drug resistance in NSCLC.”
BackgroundInfluentialSelf-citationZhang, Q., Bansal, A. K., Dunbar, K. B., Chang, Y., Zhang, J., Balaji, U., Gu, J., Zhang, X., Podgaetz, E., Pan, Z., et al. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2022 · Cited by 24
Yang, T., Sun, J., Wang, W., Li, D., Yang, X., Jia, A., Ma, Y., & Fan, Z. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04458-5 · Cited by 24
“EMT is closely related to the invasion and metastasis of tumor, which attracts more and more attention [22].”
BackgroundTanaka, M. H., Kunita, A., Yamagishi, M., Katoh, H., Ishikawa, S., Yamamoto, H., Abe, J., Arita, J., Hasegawa, K., Shibata, T., et al. (2022) · Liver International · doi:10.1111/liv.15366 · Cited by 24
New Tools for Lineage Tracing in Cancer In Vivo
Jones, M. G., Yang, D., & Weissman, J. S. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-123301 · Cited by 24
Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis
Zhang, J., Hu, Z., Chung, H. H., Tian, Y., Lau, K. W., Ser, Z., Lim, Y. T., Sobota, R. M., Leong, H. F., Chen, B. J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38132-1 · Cited by 24
Escudero-Flórez, M., Torres-Hoyos, D., Miranda-Brand, Y., Boudreau, R. L., Gallego-Gómez, J. C., & Vicente‐Manzanares, M. (2023) · Viruses · doi:10.3390/v15071437 · Cited by 24
“Recent studies have indicated that EMT/EndMT are not binary states, but there is a continuum of intermediate stages between 100% epithelial/endothelial and 100% mesenchymal [53].”
BackgroundPratelli, G., Carlisi, D., Liberto, D. D., Notaro, A., Giuliano, M., D’Anneo, A., Lauricella, M., Emanuele, S., Calvaruso, G., & Blasio, A. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311149 · Cited by 24
“During EMT, cells can be subject to dynamic changeovers from an epithelial state to a mesenchymal phenotype with consequent increase on migratory and invasive properties [16].”
BackgroundBan, Y., Zou, Y., Liu, Y., Lee, S. S., Bednarczyk, R. B., Sheng, J., Cao, Y., Wong, S. T. C., & Gao, D. (2023) · eLife · doi:10.7554/elife.89486.3 · Cited by 24
Kameyama, H., Dondapati, P., Simmons, R., Leslie, M., Langenheim, J. F., Sun, Y., Yi, M., Rottschaefer, A., Pathak, R., Nuguri, S., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101330 · Cited by 24
Snai2‐mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB
Jiang, L., Guo, S., Zhou, Z., Li, Z., Zhou, F., Yu, C., Li, M., Huang, W., Liu, Z., & Tian, X. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1555 · Cited by 24
Epithelial–Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly
Gil, J., Jordà, M., Soldevila, B., & Puig‐Domingo, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.646210 · Cited by 24
“Epithelial–mesenchymal transition (EMT) is a dynamic process that reorganizes the cell from an epithelial to a mesenchymal phenotype leading to functional changes in cell invasion and migration capacities (1).”
BackgroundFrom Neural Crest to Definitive Roof Plate: The Dynamic Behavior of the Dorsal Neural Tube
Rekler, D., & Kalcheim, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083911 · Cited by 24
“Transcription factors, regulated by the above signaling proteins, are an essential component of the molecular network leading to NC EMT and delamination [26,33,69].”
BackgroundSelf-citationSripathi, S. R., Hu, M.-W., Turaga, R. C., Mertz, J. L., Liu, M. M., Wan, J., Maruotti, J., Wahlin, K. J., Berlinicke, C. A., Qian, J. X., et al. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100131 · Cited by 24
“Epithelial cells can convert into motile mesenchymal-like cells by a process of well-defined transdifferentiation known as epithelial-to-mesenchymal transition (EMT) (1, 2).”
Junghof, J., Kogure, Y., Tian, Y., Verdugo‐Sivianes, E. M., Narita, M., Lucena-Cacace, A., & Yoshida, Y. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00207-w · Cited by 24
Guo, X., Huang, Z., Wu, F., Jiang, W., Li, Y., Wang, T., Tran, S. D., Lin, Z., & Su, X. (2024) · Theranostics · doi:10.7150/thno.102346 · Cited by 23
“Current insight into EMT suggests that relying on a few EMT molecular markers is insufficient to evaluate EMT status [65].”
Wang, T., Chen, Z., Wang, W., Wang, H., & Li, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1556386 · Cited by 23
Mascaux, C., Sen, T., Sánchez‐Céspedes, M., Ortiz‐Cuaran, S., Bossé, Y., Dammeijer, F. F., Cavic, M. R., Barr, M. P., Arulananda, S., Armisén, R., et al. (2025) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2025.05.024 · Cited by 23
Heparan Sulfate Proteoglycans (HSPGs) and Their Degradation in Health and Disease
Greco, N. M., Masola, V., & Onisto, M. (2025) · Biomolecules · doi:10.3390/biom15111597 · Cited by 23
“EMT arises from dynamic interactions between cells and their microenvironment, which drive changes in gene expression and post-translational regulatory mechanisms, ultimately promoting phenotype switching [119].”
Asadirad, A., Khodadadi, A., Talaiezadeh, A., Shohan, M., Rashno, M. M., & Joudaki, N. (2022) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2022.101831 · Cited by 23
Chemopreventive role of probiotics against cancer: a comprehensive mechanistic review
Noor, S., Ali, S., Riaz, S., Sardar, I., Farooq, M. A., & Sajjad, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08023-7 · Cited by 23
“It primarily happens as a result of cancer cells undergoing a physiological process known as epithelial-mesenchymal transition (EMT) which gives epithelial cells morphological and physiological attributes more equivalent to mesenchymal cells[67].”
BackgroundSaliem, S. S., Bede, S. Y. H., Abdulkareem, A. A., Abdullah, B. H., Milward, M. R., & Cooper, P. R. (2022) · Journal of Periodontal Research · doi:10.1111/jre.13086 · Cited by 23
Epithelial–Mesenchymal Transition Induced in Cancer Cells by Adhesion to Type I Collagen
Fujisaki, H., & Futaki, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010198 · Cited by 23
“The EMT International Association has recently published a consensus statement to provide researchers with guidelines in light of diverse reported phenotypes and numerous EMT-related factors [75].”
Background
Metadata
- Authors
- Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., Dedhar, S., Derynck, R., Ford, H. L., Fuxe, J., García de Herreros, A., Goodall, G. J., Hadjantonakis, A.-K., Huang, R. Y. J., Kalcheim, C., Kalluri, R., Kang, Y., Khew-Goodall, Y., Levine, H., Liu, J., Longmore, G. D., Mani, S. A., Massagué, J., Mayor, R., McClay, D., Mostov, K. E., Newgreen, D. F., Nieto, M. A., Puisieux, A., Runyan, R., Savagner, P., Stanger, B., Stemmler, M. P., Takahashi, Y., Takeichi, M., Theveneau, E., Thiery, J. P., Thompson, E. W., Weinberg, R. A., Williams, E. D., Xing, J., Zhou, B. P., Sheng, G., & On behalf of the EMT International Association (TEMTIA)
- Affiliations
- University of California San Diego (US)
- University of Arizona (US)
- Ghent University (BE)
- Université Libre de Bruxelles (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Sheffield (GB)
- Instituto de Investigaciones Biomédicas Sols-Morreale (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- University of Basel (CH)
- University of British Columbia (CA)
- University of California, San Francisco (US)
- University of Colorado Anschutz (US)
- Karolinska University Hospital (SE)
- South Australia Pathology (AU)
- Memorial Sloan Kettering Cancer Center (US)
- National Taiwan University (TW)
- Hebrew University of Jerusalem (IL)
- The University of Texas MD Anderson Cancer Center (US)
- Princeton University (US)
- Northeastern University (US)
- Washington University in St. Louis (US)
- University College London (GB)
- Duke University (US)
- Royal Children's Hospital (AU)
- Instituto de Neurociencias (ES)
- Lyon 1 Université (FR)
- Inserm (FR)
- University of Pennsylvania (US)
- Kyoto University (JP)
- RIKEN Center for Biosystems Dynamics Research (JP)
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory (CN)
- Translational Research Institute (AU)
- Whitehead Institute for Biomedical Research (US)
- Queensland University of Technology (AU)
- University of Pittsburgh (US)
- University of Kentucky (US)
- International Research Center for Medical Sciences, Kumamoto University (JP)
- Corresponding author
- Yang, Jing
- Sheng, Guojun
- ORCID
- Yang, Jing
- Antin, Parker
- Berx, Geert
- Blanpain, Cédric
- Brabletz, Thomas
- Campbell, Kyra
- Casanova, Jordi
- Christofori, Gerhard
- Dedhar, Shoukat
- Derynck, Rik
- Ford, Heide L.
- Fuxe, Jonas
- Goodall, Gregory J.
- Hadjantonakis, Anna-Katerina
- Huang, Ruby Y. J.
- Kalcheim, Chaya
- Kalluri, Raghu
- Kang, Yibin
- Levine, Herbert
- Liu, Jinsong
- Longmore, Gregory D.
- Mani, Sendurai A.
- Massagué, Joan
- Mayor, Roberto
- McClay, David
- Mostov, Keith E.
- Newgreen, Donald F.
- Nieto, M. Angela
- Puisieux, Alain
- Runyan, Raymond
- Savagner, Pierre
- Stanger, Ben
- Stemmler, Marc P.
- Takahashi, Yoshiko
- Takeichi, Masatoshi
- Theveneau, Eric
- Thiery, Jean Paul
- Thompson, Erik W.
- Weinberg, Robert A.
- Williams, Elizabeth D.
- Xing, Jianhua
- Zhou, Binhua P.
- Sheng, Guojun
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2020-04-16
- Volume
- 21
- Issue
- 6
- Pages
- 341-352
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC7250738
- OpenAlex
- W3016840787
- Cited by
- 2,226
- References
- 139
- Citations by year
- 2026: 249 · 2025: 382 · 2024: 403 · 2023: 396 · 2022: 386 · 2021: 313 · 2020: 88
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-10-15)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Biblos-e Archivo (Universidad Autónoma de Madrid) (submittedVersion, public-domain)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Hispana (submittedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (204615/Z/16/Z)
- Biotechnology and Biological Sciences Research Council (BB/R00627X/1, BB/T013044/1)
- Japan Society for the Promotion of Science (19H04775, 20K21425, 18H02452, 20K20520, 16KT0071)
- National Cancer Institute (R01CA223758, R37CA232209, P30CA023100, P30CA016672)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119232)
- National Institute of Environmental Health Sciences (P30ES006694)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P41HD088362)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, nomenclature, research guidelines, cell migration, cell invasion, transcription factors, cancer, developmental processes
- MeSH terms
- Cell Plasticity, Animals, Cell Movement, Humans, Neoplasms, Terminology as Topic, Developmental Biology, Consensus, Biomedical Research, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.